Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00678080 · ClinicalTrials.gov registry record · NA
Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00678080 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 25 participants.
The verdict
NCT00678080, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Pregnant women with type 2 diabetes mellitus (T2DM) are at increased risk for miscarriages, birth defects, large infants, and stillbirths. Maintaining blood sugars in the normal range decreases these pregnancy complications. We hypothesize that metformin will achieve similar levels of blood sugar control compared to insulin. In doing so, metformin will prevent the increased risk of pregnancy complications associated with T2DM in pregnancy. We propose a pilot study of a randomized, controlled trial of metformin versus insulin in the treatment of T2DM during pregnancy.
Interventions
- DRUG Metformin
- DRUG Insulin (NPH and Regular)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00678080
The ClinicalTrials.gov registry entry for NCT00678080 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT00678080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00678080 about?
NCT00678080 is a clinical study titled "Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes". Pregnant women with type 2 diabetes mellitus (T2DM) are at increased risk for miscarriages, birth defects, large infants, and stillbirths. Maintaining blood sugars in the normal range decreases these pregnancy complications. We hypothesize that metformin will achieve similar levels of blood sugar co...
What is the current status of trial NCT00678080?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2008-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00678080?
The interventions under investigation include: Metformin (DRUG), Insulin (NPH and Regular) (DRUG).
Who is sponsoring clinical trial NCT00678080?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.